TELA Deficiency Letter: $1.00 Bid Price Below Nasdaq Minimum, 180-Day Cure Period Until Sept 14 2026, Potential Transfer to Nasdaq Capital Market
TELA Bio, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $0.90
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS